US 8030445
Glycopeptide derivative
granted A61KA61K38/00A61P
Quick answer
US patent 8030445 (Glycopeptide derivative) held by Theravance, Inc. expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04